In vivo EDRF activity influences platelet function
Open Access
- 1 August 1988
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 94 (4), 1020-1022
- https://doi.org/10.1111/j.1476-5381.1988.tb11616.x
Abstract
The administration of carbachol to rabbits to stimulate the release of endothelium derived relaxing factor (EDRF) results in inhibition of platelet aggregation and elevation of platelet cyclic GMP content. These effects are reversed by simultaneous administration of the EDRF inhibitors methylene blue or haemoglobin. The data provide the first direct biochemical evidence of in vivo EDRF activity.This publication has 11 references indexed in Scilit:
- Endothelium‐derived relaxing factor inhibits in vitro platelet aggregationBritish Journal of Pharmacology, 1987
- Haptoglobin-haemoglobin complex in human plasma inhibits endothelium dependent relaxation: evidence that endothelium derived relaxing factor acts as a local autocoidCardiovascular Research, 1986
- The role of endothelium in the control of vascular toneBasic Research in Cardiology, 1985
- Release and properties of endothelium‐derived relaxing factor (EDRF) from endothelial cells in cultureJournal of Cellular Physiology, 1985
- SELECTIVE BLOCKADE OF ENDOTHELIUM-DEPENDENT AND GLYCERYL TRINITRATE-INDUCED RELAXATION BY HEMOGLOBIN AND BY METHYLENE-BLUE IN THE RABBIT AORTA1985
- The nature of endothelium-derived vascular relaxant factorNature, 1984
- Agonist-induced endothelium-dependent relaxation in rat thoracic aorta may be mediated through cGMP.Circulation Research, 1983
- MECHANISM OF VASCULAR SMOOTH-MUSCLE RELAXATION BY ORGANIC NITRATES, NITRITES, NITROPRUSSIDE AND NITRIC-OXIDE - EVIDENCE FOR THE INVOLVEMENT OF S-NITROSOTHIOLS AS ACTIVE INTERMEDIATES1981
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980